Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-14

FDA Approved: XERESE — Supplemental Application (Bausch Health US LLC)

View source ↗

Summary

The FDA approved a supplemental application for XERESE (acyclovir and hydrocortisone) from Bausch Health US LLC under NDA 022436. The approval likely involves l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XERESE (ACYCLOVIR AND HYDROCORTISONE)

Snippet

SUPPL AP for XERESE (ACYCLOVIR AND HYDROCORTISONE)